Systemic sclerosis & Raynaud's

Assessment of the Systemic Sclerosis–Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short‐Form Development

Arthritis Care Res (Hoboken)Published Instrument development study

Authors' conclusion

The ASRAP questionnaire has been developed with extensive SSc patient input, with items grounded in the lived experience of SSc-RP to ensure strong content validity, with a focus on how patients feel and function.

Study context

Population
Systemic sclerosis (SSc) patients from scleroderma centers in the UK and US over 2 consecutive winters
Participants
420 patients
Outcome
Development of the ASRAP questionnaire
Methodological detailsinternational multicenter, patient insight partner support, qualitative assessment and linguistic testing, factor analysis with item response theory, graded response model, computerized adaptive testing simulations, Patient cognitive debriefing interviews to enhance comprehension, ambiguity, cognitive difficulty, relevance and content coverage
  • International multicenter
  • Patient insight partner support
  • Qualitative assessment and linguistic testing
  • Factor analysis with item response theory
  • Graded response model
  • Computerized adaptive testing simulations
  • Patient cognitive debriefing interviews to enhance comprehension, ambiguity, cognitive difficulty, relevance and content coverage

Main finding

As reported in the abstract

Preliminary ASRAP questionnaire items

37

Additional items after expert review

2

Retained long-form ASRAP items, calibrated and scored using the graded response model

27

Fixed short-form ASRAP items, developed using computerized adaptive testing simulations

10

Original publication

Assessment of the Systemic Sclerosis–Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short‐Form Development. Arthritis Care Res (Hoboken). Published 30 January 2023. doi:10.1002/acr.25038

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.